OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany
Tjalf Ziemssen, et al.
Introduction Ozanimod is a sphingosine 1-phosphate receptor 1 and 5 modulator that blocks lymphocyte egress from lymphoid tissue, reducing the number of circulating lymphocytes in peripheral blood (1). Ozanimod was…